Literature DB >> 24227963

Methotrexate for the treatment of generalized vitiligo.

Khalid Alghamdi1, Huma Khurrum.   

Abstract

Entities:  

Year:  2013        PMID： 24227963      PMCID： PMC3824946          DOI： 10.1016/j.jsps.2012.12.003

Source DB:  PubMed          Journal:  Saudi Pharm J        ISSN： 1319-0164            Impact factor:   4.330


× No keyword cloud information.
  7 in total

1.  Immunological pathomechanisms in vitiligo.

Authors:  E H Kemp; E A Waterman; A P Weetman
Journal:  Expert Rev Mol Med       Date:  2001-07-23       Impact factor: 5.600

2.  Unstable vitiligo responding to methotrexate.

Authors:  A Sandra; S Pai; S D Shenoi
Journal:  Indian J Dermatol Venereol Leprol       Date:  1998 Nov-Dec       Impact factor: 2.545

Review 3.  A review and a new hypothesis for non-immunological pathogenetic mechanisms in vitiligo.

Authors:  Maria Lucia Dell'anna; Mauro Picardo
Journal:  Pigment Cell Res       Date:  2006-10

4.  Increased tumor necrosis factor alpha (TNF-alpha) and interleukin 1 alpha (IL1-alpha) levels in the lesional skin of patients with nonsegmental vitiligo.

Authors:  Ahu Birol; Ucler Kisa; Gulcan Saylam Kurtipek; Fatma Kara; Mukadder Kocak; Emel Erkek; Osman Caglayan
Journal:  Int J Dermatol       Date:  2006-08       Impact factor: 2.736

5.  Response to methotrexate in early rheumatoid arthritis is associated with a decrease of T cell derived tumour necrosis factor alpha, increase of interleukin 10, and predicted by the initial concentration of interleukin 4.

Authors:  M Rudwaleit; Z Yin; S Siegert; M Grolms; A Radbruch; J Braun; J Sieper
Journal:  Ann Rheum Dis       Date:  2000-04       Impact factor: 19.103

6.  Treatment of pemphigus vulgaris with methotrexate.

Authors:  W F Lever; H S Goldberg
Journal:  Arch Dermatol       Date:  1969-07

7.  Methotrexate suppresses NF-kappaB activation through inhibition of IkappaBalpha phosphorylation and degradation.

Authors:  S Majumdar; B B Aggarwal
Journal:  J Immunol       Date:  2001-09-01       Impact factor: 5.422
  7 in total
  6 in total

Review 1.  Advances in Vitiligo: An Update on Medical and Surgical Treatments.

Authors:  Alexander B Dillon; Andrew Sideris; Ali Hadi; Nada Elbuluk
Journal:  J Clin Aesthet Dermatol       Date:  2017-01-01

Review 2.  Novel immunological and genetic factors associated with vitiligo: A review.

Authors:  Salvador Luis Said-Fernandez; Celia Nohemi Sanchez-Domínguez; Mauricio Andres Salinas-Santander; Herminia Guadalupe Martinez-Rodriguez; David Emmanuel Kubelis-Lopez; Natalia Aranza Zapata-Salazar; Osvaldo Tomas Vazquez-Martinez; Uwe Wollina; Torello Lotti; Jorge Ocampo-Candiani
Journal:  Exp Ther Med       Date:  2021-02-01       Impact factor: 2.447

Review 3.  Updates and new medical treatments for vitiligo (Review).

Authors:  David Emmanuel Kubelis-López; Natalia Aranza Zapata-Salazar; Salvador Luis Said-Fernández; Celia Nohemí Sánchez-Domínguez; Mauricio Andrés Salinas-Santander; Herminia Guadalupe Martínez-Rodríguez; Osvaldo Tomás Vázquez-Martínez; Uwe Wollina; Torello Lotti; Jorge Ocampo-Candiani
Journal:  Exp Ther Med       Date:  2021-05-25       Impact factor: 2.447

4.  Combination therapy of orally administered glycyrrhizin and UVB improved active-stage generalized vitiligo.

Authors:  K H Mou; D Han; W L Liu; P Li
Journal:  Braz J Med Biol Res       Date:  2016-07-25       Impact factor: 2.590

Review 5.  Roles of inflammation factors in melanogenesis (Review).

Authors:  Chuhan Fu; Jing Chen; Jianyun Lu; Lu Yi; Xiaoliang Tong; Liyang Kang; Shiyao Pei; Yujie Ouyang; Ling Jiang; Yufang Ding; Xiaojiao Zhao; Si Li; Yan Yang; Jinhua Huang; Qinghai Zeng
Journal:  Mol Med Rep       Date:  2020-01-17       Impact factor: 2.952

6.  Effects of Omega-3 Polyunsaturated Fatty Acid Supplementation on Non-Alcoholic Fatty Liver: A Systematic Review and Meta-Analysis.

Authors:  Cheng-Han Lee; Yun Fu; Shih-Jyun Yang; Ching-Chi Chi
Journal:  Nutrients       Date:  2020-09-11       Impact factor: 5.717
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.